Literature DB >> 2160665

Influences of peripheral adrenocorticotropin 1-39 (ACTH) and human corticotropin releasing hormone (h-CRH) on human auditory evoked potentials (AEP).

J Born1, B Bathelt, R Pietrowsky, P Pauschinger, H L Fehm.   

Abstract

Hormones of the hypothalamus-pituitary-adrenal (HPA) axis have been considered to form part of an efferent humoral system modulating central nervous stimulus processing. The present experiments were designed to compare the effects of iv bolus administrations of placebo, porcine ACTH 1-39 (1.5 U) and h-CRH (25 micrograms) on auditory evoked potentials (AEPs) in healthy men. Also, cardiovascular parameters, cortisol and self-reported mood were assessed. ACTH significantly reduced the amplitude of the N1 component of the AEP; P1 and P2 remained unchanged. The selective reduction of N1 amplitude defies an interpretation of the changes in terms of a reduced stimulus-induced cortical arousal following ACTH; the ACTH-induced changes may rather indicate an influence on frontocortical functions of directing attention. The effect of ACTH on N1 cannot be attributed to its adrenocorticotropic action or to cardiovascular changes, but appears to represent an intrinsic extraadrenal influence of the hormone. The data do not provide evidence for effects of h-CRH on central nervous stimulus processing in humans, after peripheral administration.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2160665     DOI: 10.1007/BF02253714

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  23 in total

1.  Some effects of an ACTH 4-9 analog (Org 2766) on human performance.

Authors:  A W Gaillard; C A Varey
Journal:  Physiol Behav       Date:  1979-07

2.  Fragments of ACTH affect electrophysiological signs of controlled stimulus processing in humans.

Authors:  J Born; W Kern; R Pietrowsky; W Sittig; H L Fehm
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

3.  An ACTH 4-9 analog impairs selective attention in man.

Authors:  J Born; G Fehm-Wolfsdorf; M Schiebe; N Birbaumer; H L Fehm; K H Voigt
Journal:  Life Sci       Date:  1985-06-03       Impact factor: 5.037

4.  Effects of corticotropin-releasing factor and growth hormone-releasing factor on sleep and activity in rats.

Authors:  C L Ehlers; T K Reed; S J Henriksen
Journal:  Neuroendocrinology       Date:  1986       Impact factor: 4.914

5.  Telemetered recording of hormone effects on hippocampal neurons.

Authors:  D W Pfaff; M T Silva; J M Weiss
Journal:  Science       Date:  1971-04-23       Impact factor: 47.728

6.  Dishabituating effects of an ACTH 4-9 analog in a vigilance task.

Authors:  J Born; G Fehm-Wolfsdorf; M Schiebe; B Rockstroh; H L Fehm; K H Voigt
Journal:  Pharmacol Biochem Behav       Date:  1984-10       Impact factor: 3.533

7.  Presence of corticotropin releasing factor-like immunoreactivity in hypophysial portal blood.

Authors:  D M Gibbs; W Vale
Journal:  Endocrinology       Date:  1982-10       Impact factor: 4.736

8.  Subcortical correlates of the somatic, auditory and visual vertex activities in man. I. Bipolar EEG responses and electrical stimulation.

Authors:  M Velasco; F Velasco; A Olvera
Journal:  Electroencephalogr Clin Neurophysiol       Date:  1985-12

9.  Comparison of adrenocorticotropin control in Brattleboro, Long-Evans, and Wistar rats. Measurement of corticotropin-releasing factor, arginine vasopressin, and oxytocin in hypophysial portal blood.

Authors:  L A Tannahill; R C Dow; K M Fairhall; I C Robinson; G Fink
Journal:  Neuroendocrinology       Date:  1988-12       Impact factor: 4.914

10.  Immunoreactive corticotropin-releasing factor in human plasma.

Authors:  T Suda; N Tomori; F Yajima; T Sumitomo; Y Nakagami; T Ushiyama; H Demura; K Shizume
Journal:  J Clin Invest       Date:  1985-11       Impact factor: 14.808

View more
  1 in total

1.  Oxytocin increases the influence of public service advertisements.

Authors:  Pei-Ying Lin; Naomi Sparks Grewal; Christophe Morin; Walter D Johnson; Paul J Zak
Journal:  PLoS One       Date:  2013-02-27       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.